Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07002320 |
| Title | Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer (ASpiRE) |
| Acronym | ASpiRE |
| Recruitment | Recruiting |
| Gender | male |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Institute of Cancer Research, United Kingdom |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | GBR | CHE |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Oncology Institute of Southern Switzerland | NOT_YET_RECRUITING | Bellinzona | CH6500 | Switzerland | Details | |
| Belfast Health and Social Care Trust | RECRUITING | Belfast | BT9 7AB | United Kingdom | Details | |
| Cambridge University Hospitals NHS Foundation Trust | RECRUITING | Cambridge | CB2 0QQ | United Kingdom | Details | |
| The Royal Marsden NHS Foundation Trust - Drug Development Unit | RECRUITING | Sutton | SM2 5PT | United Kingdom | Details |